74 Comments
⭠ Return to thread

I'm no virologist but here's a simple question: If Sars Cov-2 can be dealt with by the innate immune system (either symptomatically or asymptomatically) or, at most, via short-lived adaptive responses at the mucosa and never goes systemic, how the heck would you know whether the "vaccine" prevented severe disease? Given that these shots do not reliably create mucosal immunity (thus preventing infection), there is no way to prove the shots prevent severe disease (systemic) in anyone who doesn't get that far in the disease process (the transfection-induced antigen-specific antibodies are systemic).

It's like giving credit to the presence of a security guard inside the vault (that nobody has ever seen) when the bank robbers are constantly thwarted outside or inside the bank by the armed guards there.

Expand full comment

They also used rhesus macaque monkeys in the vaccine efficacy trials. Macaques are not at all or hardly at all impacted by SARS-COV-2 so challenge studies after injection mean nothing as exposure had no impact before injection. Scientists recommend they only use aged mice in any efficacy and safety trials for products intended for use in humans.

Expand full comment